Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification

Fahad Alajmi1, Mehima Kang1, James Dundas2,3

  • 1Center for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, 2775 Laurel St, 9th Floor, Vancouver, BC V5Z 1M9, Canada.

Life (Basel, Switzerland)
|February 24, 2024
PubMed

Insights

Novel cardiac magnetic resonance imaging (CMR) parameters show potential for improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy (HCM). These advanced techniques may enhance diagnosis and prognosis for HCM patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart condition.
  • Sudden cardiac death (SCD) is a significant risk in HCM patients.
  • Current risk stratification methods for HCM have limitations.

Purpose of the Study:

  • To review novel cardiac magnetic resonance imaging (CMR) parameters.
  • To assess the utility of these novel CMR markers in HCM risk stratification.
  • To discuss the potential implementation of these techniques in clinical practice.

Main Methods:

  • Literature review of recent studies on novel CMR techniques in HCM.
  • Analysis of parameters such as T1, extracellular volume, and CMR feature tracking.
  • Evaluation of the strengths and weaknesses of these imaging modalities.

Main Results:

  • Novel CMR parameters, including T1 mapping and extracellular volume quantification, show promise.
  • CMR feature tracking offers additional insights into myocardial mechanics.
  • These novel variables have the potential to improve SCD risk stratification in HCM.

Conclusions:

  • Advanced CMR techniques offer improved risk stratification for sudden cardiac death in HCM.
  • These methods may also play a role in the diagnosis and prognosis of HCM.
  • Further research and validation are needed for widespread clinical implementation.